Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of GL701 in Men With Systemic Lupus Erythematosus

NCT00037128 is registered in ClinicalTrials.gov with Genelabs Technologies as lead sponsor.

NCT NCT00037128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of GL701 in Men With Systemic Lupus Erythematosus
Lead sponsor
Genelabs Technologies
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 1998
Completion date
Not reported
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus